The present and future opportunities of the Rare Cancer Network: an international consortium for advancement of oncologic care
To date, the <em>Rare Cancer Network</em> (RCN) has initiated more than 90 studies and 54 peer-reviewed publications were produced as a result. The Second International Symposium of the Rare Cancer Network recently took place in Istanbul, Turkey on April 17-18, 2015, and update was given...
Main Author: | The Rare Cancer Network |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-10-01
|
Series: | Rare Tumors |
Online Access: | http://www.pagepress.org/journals/index.php/rt/article/view/5998 |
Similar Items
-
The COVID-19 & Cancer Consortium (CCC19) and Opportunities for Radiation Oncology
by: Sachin R. Jhawar, MD, MSCI, et al.
Published: (2021-01-01) -
Oncological outcome after lung metastasis in patients presenting with localized chondrosarcoma at extremities: Tokai Musculoskeletal Oncology Consortium study
by: Nakamura T, et al.
Published: (2016-07-01) -
The Swiss Industrial Biocatalysis Consortium (SIBC): Past, Present and Future
by: Steven Hanlon
Published: (2020-05-01) -
Tumor Growth Dynamic Modeling in Oncology Drug Development and Regulatory Approval: Past, Present, and Future Opportunities
by: Nidal Al‐Huniti, et al.
Published: (2020-08-01) -
Recent advances in liver transplantation for cancer: The future of transplant oncology
by: Phillipe Abreu, et al.
Published: (2019-11-01)